1 – 10 of 253
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis : Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network
- Immune tolerance induction : What have we learned over time?
- Evaluation of prophylactic therapy in haemophilia with global coagulation tests
- 2017
- Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits : A two-centre study
- Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy : The Malmö experience
- Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
- The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
- European retrospective study of real-life haemophilia treatment
- Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics
- Plasma products do not solve the inhibitor problem